ENTRY       D06553                      Drug
NAME        Alogliptin benzoate (JAN/USAN);
            Vipidia (TN);
            Nesina (TN)
PRODUCT     NESINA (Takeda Pharmaceuticals America)
  GENERIC   ALOGLIPTIN (A-S Medication Solutions)
            ALOGLIPTIN (Aphena Pharma Solutions - Tennessee)
            ALOGLIPTIN (Aphena Pharma Solutions - Tennessee)
            ALOGLIPTIN (Padagis Israel Pharmaceuticals)
FORMULA     C18H21N5O2. C7H6O2
EXACT_MASS  461.2063
MOL_WEIGHT  461.513
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG01601  DPP-4 inhibitor
REMARK      Therapeutic category: 3969
            ATC code: A10BH04
            Product: D06553<JP/US>
            Product (mixture): D10159<JP/US> D10253<JP/US>
EFFICACY    Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
COMMENT     Treatment of type 2 diabetes
TARGET      DPP4 (CD26) [HSA:1803] [KO:K01278]
  PATHWAY   hsa04974(1803)  Protein digestion and absorption
INTERACTION  
STR_MAP     map07051  Antidiabetics
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
                 A10BH04 Alogliptin
                  D06553  Alogliptin benzoate (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Agents
               Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
                Alogliptin
                 D06553  Alogliptin benzoate (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               396  Antidiabetic agents
                3969  Others
                 D06553  Alogliptin benzoate (JAN/USAN)
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG01601  DPP-4 inhibitor
                D06553  Alogliptin benzoate
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG01601  DPP-4 inhibitor
               D06553  Alogliptin benzoate
              DG02044  Hypoglycemic agent
               D06553  Alogliptin benzoate
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Peptidyl-peptidases
                DPP4 (CD26)
                 D06553  Alogliptin benzoate (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D06553
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D06553
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D06553
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D06553
DBLINKS     CAS: 850649-62-6
            PubChem: 47208209
            ChEBI: 72324
            LigandBox: D06553
ATOM        34
            1   C8x C    11.4100  -16.3100
            2   C8x C    11.4100  -17.7100
            3   C8x C    12.6224  -18.4100
            4   C8x C    13.8349  -17.7100
            5   C8y C    13.8349  -16.3100
            6   C8y C    12.6224  -15.6100
            7   C8y C    16.2597  -17.7100
            8   N4y N    16.2597  -16.3100
            9   C1b C    15.0473  -15.6100
            10  N4y N    17.4722  -18.4100
            11  C8y C    18.6846  -17.7100
            12  C8x C    18.6846  -16.3100
            13  C8y C    17.4722  -15.6100
            14  C3b C    12.6224  -14.2102
            15  N3a N    12.6224  -12.8102
            16  O5x O    15.0326  -18.4186
            17  C1a C    17.4722  -19.8097
            18  O5x O    19.9011  -18.4123
            19  N1y N    17.4722  -14.2103
            20  C1x C    18.7054  -13.4980
            21  C1x C    18.7052  -12.0980
            22  C1x C    17.4926  -11.3982
            23  C1y C    16.2594  -12.1105
            24  C1x C    16.2596  -13.5105
            25  N1a N    15.0322  -11.4021
            26  C8y C    23.9402  -15.6465
            27  C8x C    22.7305  -16.3378
            28  C8x C    25.1564  -16.3378
            29  C6a C    23.9339  -14.2511
            30  C8x C    22.7305  -17.7461
            31  C8x C    25.1564  -17.7461
            32  O6a O    25.1371  -13.5534
            33  O6a O    22.7240  -13.5599
            34  C8x C    23.9402  -18.4565
BOND        36
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     7   8 1
            8     8   9 1
            9     5   9 1
            10    7  10 1
            11   10  11 1
            12   11  12 1
            13   12  13 2
            14    8  13 1
            15    6  14 1
            16   14  15 3
            17    7  16 2
            18   10  17 1
            19   11  18 2
            20   13  19 1
            21   19  20 1
            22   20  21 1
            23   21  22 1
            24   22  23 1
            25   23  24 1
            26   19  24 1
            27   23  25 1 #Down
            28   26  27 2
            29   26  28 1
            30   26  29 1
            31   27  30 1
            32   28  31 2
            33   29  32 1
            34   29  33 2
            35   30  34 2
            36   31  34 1
///
